Platelet-rich plasma

Rejuvenating Fertility Center Updates Its IVF Plus Program and its Financing Options Amid Inflation

Retrieved on: 
Tuesday, March 7, 2023
Transfer, LendingClub, Ozone, Patient, Freezing, PCOS, Infertility, Hysterosalpingography, Risk, Fertility, Fertilisation, Lipid emulsion, Male, HSG, PRP, RFC, Polycystic disease, Woman, Cryopreservation, ICSI, Platelet-rich plasma, PGT, Diagnosis, Genetic testing, Polycystic ovary syndrome, Family, IVF, STD, Semen analysis, SIS, Pregnancy, FET, Birth control, Mineral oil

The comprehensive IVF treatment program at Rejuvenating Fertility Center covers three cycles to be completed within 9 months from the start of the first cycle.

Key Points: 
  • The comprehensive IVF treatment program at Rejuvenating Fertility Center covers three cycles to be completed within 9 months from the start of the first cycle.
  • With the IVF + Guaranteed Program at RFC, cycle monitoring will be covered when performed at the center.
  • RFC also introduces new financing options in response to inflation:
    CapexMD is known for offering financing options for all types of fertility treatments.
  • Rejuvenating Fertility Center is a medical center specializing in the field of reproductive endocrinology and infertility.

Rejuvenating Fertility Center Announces New Treatment Options for Menopausal Women

Retrieved on: 
Tuesday, March 7, 2023
Research, Platelet-rich plasma, Blood, Ozone, Regeneration, Dentistry, Plasma, Infertility, Dermatology, Hormone, Life, Oxygen, Fertility, Hair loss, B cell, PRP, RFC, Patient, Inflammation, Woman, Menopause, Human, Egg, Pain, OST, Bone marrow, Elective surgery, Ovarian reserve, IVF, Arthralgia, Family, Pregnancy, Stem cell, Tendinopathy, Ovarian follicle, Birth control, Medical imaging, Aphrodite

Manhattan, New York--(Newsfile Corp. - March 6, 2023) - The east coast based fertility clinic Rejuvenating Fertility Center (RFC) has announced new treatment options for menopausal women hoping to achieve pregnancy.

Key Points: 
  • Manhattan, New York--(Newsfile Corp. - March 6, 2023) - The east coast based fertility clinic Rejuvenating Fertility Center (RFC) has announced new treatment options for menopausal women hoping to achieve pregnancy.
  • For fertility, PRP can re-awaken dormant cells and eggs inside the ovaries, allowing even menopausal women to become pregnant.
  • Ozone sauna therapy is considered to be a valuable complementary holistic treatment for women attempting pregnancy later in life, particularly those over the age of 35.
  • Rejuvenating Fertility Center is a medical center specializing in the field of reproductive endocrinology and infertility.

CO2 Medical Laser Systems Market Report 2023: Sector to Reach $1.06 Billion by 2030 at a 10% CAGR - ResearchAndMarkets.com

Retrieved on: 
Tuesday, March 14, 2023
Medical Devices, Health, Stellar, Elective surgery, Dermatology, USD, Scar, Hospital, Platelet-rich plasma, Incidence, Laser, Growth, CO2, Aesthetics, Chapter Four, Burns, Chapter Three, Speciality chemicals, Medical imaging, Application

The "CO2 Medical Laser Systems Market Size, Share & Trends Analysis Report By End-user (Hospitals, Outpatient Facilities), By Application (Dermatology, Veterinary), By Region (North America, Asia Pacific), And Segment Forecasts, 2023 - 2030" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "CO2 Medical Laser Systems Market Size, Share & Trends Analysis Report By End-user (Hospitals, Outpatient Facilities), By Application (Dermatology, Veterinary), By Region (North America, Asia Pacific), And Segment Forecasts, 2023 - 2030" report has been added to ResearchAndMarkets.com's offering.
  • The global CO2 medical laser systems market size is anticipated to reach USD 1.06 billion by 2030, registering a CAGR of 10.00% from 2023 to 2030.
  • Evolving technologies, which can enable the implementation of laser resurfacing technologies in additional treatment possibilities, are projected to promote market growth.
  • Therefore, the introduction of technologically advanced devices by key players is also estimated to drive the market.

Androgenetic Alopecia Epidemiology Forecast 2023 -2032 - ResearchAndMarkets.com

Retrieved on: 
Tuesday, March 14, 2023
Health, Other Health, History, Woman, Biopsy, Pattern hair loss, United Kingdom, Dutasteride, Classification, Scalp, Loss, Puberty, SME, Hair, Dermatoscopy, Epidemiology, Head, Platelet-rich plasma, Hair loss, EU4, Patient, Androgen, Cyproterone acetate, Food, Diagnosis, Spironolactone, FDA, Finasteride, Risk, Male, US Foods, Vaccine, Generic drug, Dentistry, Management, Pharmaceutical industry, Nursing

This 'Androgenetic Alopecia - Epidemiology Forecast - 2032' report delivers an in-depth understanding of the historical and forecasted epidemiology of androgenetic alopecia in the United States, EU4 (Germany, Spain, Italy, France) and the United Kingdom and Japan.

Key Points: 
  • This 'Androgenetic Alopecia - Epidemiology Forecast - 2032' report delivers an in-depth understanding of the historical and forecasted epidemiology of androgenetic alopecia in the United States, EU4 (Germany, Spain, Italy, France) and the United Kingdom and Japan.
  • The disease epidemiology covered in the report provides historical and forecasted androgenetic alopecia epidemiology segmented as the total prevalent cases of androgenetic alopecia, total prevalent cases of androgenetic alopecia in males, total prevalent cases of androgenetic alopecia in females, total diagnosed prevalent cases of androgenetic alopecia in males and total diagnosed prevalent cases of androgenetic alopecia in females.
  • The report describes Androgenetic Alopecia epidemiology by the number of patients developing androgenetic alopecia in the 7MM.
  • The report describes the androgenetic alopecia epidemiology by the type-specific cases of androgenetic alopecia patients in the 7MM.

Dr. John Kahen, MD of Beverly Hills Hair Restoration Granted Patent for SmartPRP®

Retrieved on: 
Tuesday, March 7, 2023
Scar, Patent, Plasma, Lower segment Caesarean section, Platelet-rich plasma, Survival, Hair, Patient, Dentistry

LOS ANGELES, March 7, 2023 /PRNewswire/ -- Dr. John Kahen announces the issuance of Smart PRP (Platelet-Rich Plasma), patent no US 10,456,422b2, an exclusive and safer healing solution for hair restoration surgery.

Key Points: 
  • LOS ANGELES, March 7, 2023 /PRNewswire/ -- Dr. John Kahen announces the issuance of Smart PRP (Platelet-Rich Plasma), patent no US 10,456,422b2, an exclusive and safer healing solution for hair restoration surgery.
  • This groundbreaking patented remedy incorporates mending the surgical wound from the transferred hair follicles, which should ensure a high survival rate for the hair follicle graft.
  • His scientific modus is the new state-of-the-art technique in which hair restoration should be performed, going into the future.
  • "I have been exclusively implementing SmartPRP during my hair transplant procedures for more than 10 years," says Dr. Kahen.

Long-Duration Ultrasound Treatment With sam® Elevates Regenerative Medicine Options for Patients

Retrieved on: 
Monday, December 12, 2022
Federation, History of Sufism, NBA, Sports medicine, Rehabilitation, Inflammation, Cytokine, ACC, FDA, MLS, Regenerative medicine, Pain, MLB, Therapeutic ultrasound, WBNA, Platelet-rich plasma, NFL, NHL, Injection, PRP, Athlete, Patient, Pharmaceutical industry, Medical imaging

"Sustained acoustic medicine is a powerful mechanobiological treatment modality," said Dr. George Lewis, founder and CEO of ZetrOZ Systems.

Key Points: 
  • "Sustained acoustic medicine is a powerful mechanobiological treatment modality," said Dr. George Lewis, founder and CEO of ZetrOZ Systems.
  • "Each treatment increases vessel diameter to boost blood flow over several hours, accelerating tissue healing and delivering a significant reduction in pain for patients.
  • The use of ultrasound and shockwave treatment in the clinical setting to complement rehabilitation and regenerative medicine is broadly used.
  • The technology can serve as a standalone treatment or adjunct to other treatment options for patients to stimulate soft-tissue repair.

Bocox™ for Erectile Dysfunction Announced by the Cellular Medicine Association

Retrieved on: 
Thursday, December 8, 2022
Faculty, CMA, Penis, Platelet-rich plasma, LD50, Advertising, ED, Patient, Research, Brianna Bocox, FDA, Urinary incontinence, Anorgasmia, Woman, Face, Aesthetics, Erectile dysfunction, Safety, Physician, Sildenafil, Urology, Cairo University, Directory, Pharmaceutical industry, Real estate, MD, Andrology

FAIRHOPE, Ala., Dec. 8, 2022 /PRNewswire/ -- Recently, faculty urologists from the Andrology Department of Cairo University of Medicine (Cairo, Egypt) published (in Andrology) a double-blind, randomized, placebo-controlled prospective clinical trial which showed that cosmetic BOTOX® improves erection better than placebo—for up to six months. In the study (as in other studies), not all men were helped, but some saw stronger erections with BOTOX® on the penis even when they were not helped by Viagra® and other drugs.

Key Points: 
  • One of the difficulties faced by clinicians in offering BOTOX therapy for the ED has been the lack of a standardized method based on the research.
  • The Bocox procedure uses similar amounts to what is routinely used for the off-label treatment of wrinkles in the face.
  • Runels also developed a way to combine the Bocox procedure with his P-Shot procedure for a synergy of improvements in erection firmness & penile health.
  • Physicians of the CMA conduct and consult regarding research in the areas of esthetics, erectile dysfunction, urinary incontinence, orgasmic dysfunction in women, lichen sclerosus, & other treatments of many other problemsusing cellular therapies, especially blood-derived growth factors, including platelet-rich plasma.

Doctors at Michigan Center for Regenerative Medicine Applaud Revolutionary sam® Device for Improving Soft Tissue Healing

Retrieved on: 
Tuesday, November 15, 2022
History of Sufism, Patient, Injury, Metro, Platelet-rich plasma, Pain, Spinal cord injury, Physician, Chronic pain, Regenerative medicine, Elbow, Arthritis, Plasma protein binding, Sports medicine, MD, Biceps tendon rupture, West Michigan Center for Art and Technology, Rehabilitation, Pain management, Federation, Myalgia, Dentistry, Pharmaceutical industry, Fred Lecklider

Doctors at the Michigan Center for Regenerative Medicine report seeing faster patient recovery and improvements in chronic pain when using regenerative medicine procedures like the sam device for treating sports injuries, lower back pain, other spinal injuries, arthritis, premature aging and more.

Key Points: 
  • Doctors at the Michigan Center for Regenerative Medicine report seeing faster patient recovery and improvements in chronic pain when using regenerative medicine procedures like the sam device for treating sports injuries, lower back pain, other spinal injuries, arthritis, premature aging and more.
  • The sam device has shown to be great for chronic tendon and muscle pain and recovery," said Dr. Thomas Nabity, MD, of the Michigan Center for Regenerative Medicine.
  • The Michigan Center for Regenerative Medicine also has a patented regenerative medicine processing lab for creating platelet-rich plasma, bone marrow concentrate stem cells, and micro-fragmented adipose tissue.
  • ZetrOZ Systems is leading healing innovations in sports medicine and developing wearable bioelectronic devices for the delivery of sustained acoustic medicine (sam).

Crown Aesthetics Announces Revolutionary Study Proving Efficacy of Patented Xycrobe® Technology

Retrieved on: 
Tuesday, November 22, 2022
Eclipse, PRP, Element, Bacteria, Health, Rejuvenation, Skin, Journal of Cosmetic Dermatology, Research, FDA, Ageing, Platelet-rich plasma, Philosophy, Doctor of Philosophy, Journal, Quality of life, Safety, Multimedia, Trial of the century, Life, Exocrine gland, Cosmetic, Symbiosis, Aesthetics, Cosmetics, Pharmaceutical industry, Dermatology, Crown

DALLAS, Nov. 22, 2022 /PRNewswire/ -- Crown Aesthetics, a Crown Laboratories, Inc. company, maintains its position at the forefront of skincare innovation with the unveiling of a new study in the Journal of Cosmetic Dermatology showcasing the efficacy of its patented Xycrobe® technology, formulated to address the often overlooked skin biome. Xycrobe technology targets certain skin conditions and cosmetic treatments using an isolated, living strain of skin-relevant bacteria. 

Key Points: 
  • DALLAS, Nov. 22, 2022 /PRNewswire/ -- Crown Aesthetics, a Crown Laboratories, Inc. company, maintains its position at the forefront of skincare innovation with the unveiling of a new study in the Journal of Cosmetic Dermatology showcasing the efficacy of its patented Xycrobe technology, formulated to address the often overlooked skin biome.
  • Xycrobe technology targets certain skin conditions and cosmetic treatments using an isolated, living strain of skin-relevant bacteria.
  • "The proven efficacy of this patented Xycrobe technology reinforces the idea that the human body depends on symbiosis.
  • Crown Aesthetics, the premier medical aesthetics company, is dedicated to helping leading aesthetic practices around the world grow their businesses.

Irwin Naturals Looks to Add Pacific Northwest Ketamine Clinic to Its National Footprint

Retrieved on: 
Wednesday, November 9, 2022
Investor, CSE, GLOBE, CRNA, OTC, PLLC, Bloomberg, CBD, Platelet-rich plasma, Injection, Mental health, FRA, Canadian Securities Exchange, The Wall Street Journal, APRN, Company, Anesthesia, PRP, Nursing, Cannabis, CEO, Acquisition, Trust, Medicine, Pharmaceutical industry

This will be the first facility in Washington for Irwin Naturals Emergence, a fast-growing national chain of psychedelic mental-health clinics.

Key Points: 
  • This will be the first facility in Washington for Irwin Naturals Emergence, a fast-growing national chain of psychedelic mental-health clinics.
  • Becoming part of Irwin Naturals Emergence gives us a chance to join something bigger that will create change on a truly national scale.
  • The Company has sought to add those clinics that meet these criteria to Irwin Naturals Emergence, which is a wholly owned subsidiary of Irwin Naturals.
  • Klee Irwin, Irwin Naturals CEO, We are a nationally known brand that our customers know and trust.